References
- Jeng JS, Su TC. Epidemiological studies of cerebrovascular diseases and carotid atherosclerosis in Taiwan. Acta Neurol Taiwan 2007;16(4):190–202.
- Directorate General of Budget. Accounting and Statistics. Statistical yearbook of the Republic of China 2009. Taipei: Directorate General of Budget, Accounting and Statistics, Executive Yuan, Republic of China, 2009.
- Leung KK, Tang LY, Chie WC, Mortality trends of elderly people in Taiwan from 1974 to 1994. Age Ageing 1999;28(2):199–203.
- Hung TP. Changes in mortality from cerebrovascular disease and clinical pattern of stroke in Taiwan. J Formos Med Assoc 1993;92(8):687–96.
- Hu HH, Chu FL, Wong WJ, Trends in mortality from cerebrovascular disease in Taiwan. Stroke 1986;17(6): 1121–5.
- Fuh JL, Wang SJ, Liu HC, Shyu HY. Incidence of stroke on Kinmen, Taiwan. Neuroepidemiology 2000;19(5):258–64.
- Liu HC, Lin RS, Lin RS. Urban and rural difference in prevalence and incidence of stroke in 2000 in Taiwan. Taiwan J Public Health 2006;25:223–30.
- Chien KL, Sung FC, Hsu HC, Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: report of the Chin-Shan Community Cardiovascular Study. Stroke 2002;33(1):39–44.
- Fuh JL, Wang SJ, Larson EB, Liu HC. Prevalence of stroke in Kinmen. Stroke 1996;27(8):1338–41.
- Chien KL, Hsu HC, Sung FC, Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 2007;194(1):214–221.
- Chien KL, Hsu HC, Sung FC, Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 2005;183(1):147–55.
- Chen JH, Chuang SY, Chen HJ, Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009;61(2):225–32.
- Lien LM, Chen WH, Chiu HC, High titer of anticardiolipin antibody is associated with first-ever ischemic stroke in Taiwan. Cerebrovasc Dis 2006;22(4):225–30.
- Carod-Artal FJ, Ferreira CL, Trizotto DS, Menezes MC. Burden and perceived health status among caregivers of stroke patients. Cerebrovasc Dis 2009;28(5):472–80.
- Carod-Artal FJ, Egido JA. Quality of life after stroke: the importance of a good recovery. Cerebrovasc Dis 2009;27(Suppl 1):204–14.
- Martinez-Vila E, Irimia P. The cost of stroke. Cerebrovasc Dis 2004;17 (Suppl 1):124–9.
- Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002–2030. Ann Trop Med Parasitol 2006;100(5–6):481–99.
- World Health Organization. The global burden of disease: 2004 update. Geneva: WHO; 2008.
- Chen CY, Lee KT, Lee TC, Lai WT, Huang YB. Epidemiology and disease burden of ulcerative colitis in Taiwan: a nationwide population-based study. Value in health regional issues 2013;2(1):127–134.
- Cheng CL, Kao YH, Lin SJ, Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20(3): 236–42.
- Mathers CD, Vos T, Lopez AD, Ezzati M. National Burden of Disease Studies: A Practical Guide. Edition 2.0. Geneva, World Health Organization 2001.
- Creutzfeldt CJ, Holloway RG. Treatment decisions after severe stroke: uncertainty and biases. Stroke 2012;43(12):3405–8.
- Carod-Artal FJ. Determining quality of life in stroke survivors. Expert Rev Pharmacoecon Outcomes Res 2012;12(2): 199–211.